{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "27", "@timestamp": "2020-03-27T15:34:31.000031-04:00", "@year": "2020", "@month": "03"}, "ait:date-sort": {"@day": "28", "@year": "2016", "@month": "08"}}, "xocs:meta": {"xocs:funding-list": {"@pui-match": "primary", "@has-funding-info": "1", "xocs:funding": [{"xocs:funding-agency-matched-string": "NIH", "xocs:funding-agency-acronym": "NIH", "xocs:funding-agency": "National Institutes of Health", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000002", "xocs:funding-agency-country": "http://sws.geonames.org/6252001/"}, {"xocs:funding-agency-acronym": "NCI", "xocs:funding-agency": "National Cancer Institute", "xocs:funding-id": "R01CA195558", "xocs:funding-agency-id": "http://data.elsevier.com/vocabulary/SciValFunders/100000054", "xocs:funding-agency-country": "http://sws.geonames.org/6252001"}], "xocs:funding-addon-generated-timestamp": "2024-01-25T04:46:07.949484Z", "xocs:funding-text": "This work was supported by grants from NIH ( CA195558 ), Experiment.com , and an ADVANCE Opportunity Grant to M.M.M.", "xocs:funding-addon-type": "http://vtw.elsevier.com/data/voc/AddOnTypes/50.7/aggregated-refined"}}, "bibrecord": {"head": {"author-group": [{"affiliation": {"country": "United States", "address-part": "10900 Euclid Avenue", "postal-code": "44106", "@afid": "60006404", "@country": "usa", "city": "Cleveland", "organization": [{"$": "Department of Pharmacology"}, {"$": "Case Western Reserve University School of Medicine"}], "affiliation-id": {"@afid": "60006404", "@dptid": "105372621"}, "state": "OH", "@dptid": "105372621"}, "author": [{"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Ketchart", "@auid": "37029887800", "ce:indexed-name": "Ketchart W."}, {"ce:given-name": "I-Ju", "preferred-name": {"ce:given-name": "I. Ju", "ce:initials": "I.J.", "ce:surname": "Yeh", "ce:indexed-name": "Yeh I.J."}, "@seq": "2", "ce:initials": "I.-J.", "@_fa": "true", "@type": "auth", "ce:surname": "Yeh", "@auid": "55926317600", "ce:indexed-name": "Yeh I.-J."}, {"ce:given-name": "Monica M.", "preferred-name": {"ce:given-name": "Monica M.", "ce:initials": "M.M.", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, "@seq": "9", "ce:initials": "M.M.", "@_fa": "true", "@type": "auth", "ce:surname": "Montano", "@auid": "16181708800", "ce:indexed-name": "Montano M.M."}]}, {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Pharmacology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425668"}, "@dptid": "104425668"}, "author": [{"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "@type": "auth", "ce:surname": "Ketchart", "@auid": "37029887800", "ce:indexed-name": "Ketchart W."}]}, {"affiliation": {"country": "United States", "address-part": "10900 Euclid Avenue", "postal-code": "44106", "@afid": "60006404", "@country": "usa", "city": "Cleveland", "organization": [{"$": "Department of Radiology"}, {"$": "Case Western Reserve University School of Medicine"}], "affiliation-id": {"@afid": "60006404", "@dptid": "103363818"}, "state": "OH", "@dptid": "103363818"}, "author": [{"ce:given-name": "Haoyan", "preferred-name": {"ce:given-name": "Haoyan", "ce:initials": "H.", "ce:surname": "Zhou", "ce:indexed-name": "Zhou H."}, "@seq": "3", "ce:initials": "H.", "@_fa": "true", "@type": "auth", "ce:surname": "Zhou", "@auid": "57202096401", "ce:indexed-name": "Zhou H."}, {"ce:given-name": "Agata", "preferred-name": {"ce:given-name": "Agata", "ce:initials": "A.", "ce:surname": "Exner", "ce:indexed-name": "Exner A."}, "@seq": "7", "ce:initials": "A.", "@_fa": "true", "@type": "auth", "ce:surname": "Exner", "@auid": "6602815053", "ce:indexed-name": "Exner A."}]}, {"affiliation": {"country": "United States", "address-part": "9500 Euclid Ave.", "postal-code": "44195", "@afid": "60021160", "@country": "usa", "city": "Cleveland", "organization": [{"$": "Department of Cellular and Molecular Medicine"}, {"$": "Cleveland Clinic Lerner Research Institute"}], "affiliation-id": {"@afid": "60021160", "@dptid": "113253819"}, "state": "OH", "@dptid": "113253819"}, "author": [{"ce:given-name": "Praveena S.", "preferred-name": {"ce:given-name": "Praveena S.", "ce:initials": "P.S.", "ce:surname": "Thiagarajan", "ce:indexed-name": "Thiagarajan P.S."}, "@seq": "4", "ce:initials": "P.S.", "@_fa": "true", "@type": "auth", "ce:surname": "Thiagarajan", "@auid": "54279713300", "ce:indexed-name": "Thiagarajan P.S."}, {"ce:given-name": "Justin", "preferred-name": {"ce:given-name": "Justin", "ce:initials": "J.", "ce:surname": "Lathia", "ce:indexed-name": "Lathia J."}, "@seq": "5", "ce:initials": "J.", "@_fa": "true", "@type": "auth", "ce:surname": "Lathia", "@auid": "6603658152", "ce:indexed-name": "Lathia J."}, {"ce:given-name": "Ofer", "preferred-name": {"ce:given-name": "Ofer", "ce:initials": "O.", "ce:surname": "Reizes", "ce:indexed-name": "Reizes O."}, "@seq": "6", "ce:initials": "O.", "@_fa": "true", "@type": "auth", "ce:surname": "Reizes", "@auid": "6603336462", "ce:indexed-name": "Reizes O."}]}, {"affiliation": {"country": "United States", "address-part": "2121 Euclid Ave.", "postal-code": "44115", "@afid": "60004154", "@country": "usa", "city": "Cleveland", "organization": [{"$": "Department of Chemistry"}, {"$": "College of Sciences and Health Professions"}, {"$": "Cleveland State University"}], "affiliation-id": {"@afid": "60004154", "@dptid": "100278189"}, "state": "OH", "@dptid": "100278189"}, "author": [{"ce:given-name": "Bin", "preferred-name": {"ce:given-name": "Bin", "ce:initials": "B.", "ce:surname": "Su", "ce:indexed-name": "Su B."}, "@seq": "8", "ce:initials": "B.", "@_fa": "true", "@type": "auth", "ce:surname": "Su", "@auid": "35340102700", "ce:indexed-name": "Su B."}]}], "citation-title": "Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism", "abstracts": "\u00a9 2016.We have been studying the role of Hexamethylene bisacetamide (HMBA) Induced Protein 1 (HEXIM1) as a tumor suppressor whose expression is decreased in tamoxifen resistant and metastatic breast cancer. HMBA was considered the most potent and specific inducer for HMBA inducible protein 1 (HEXIM1) prior to our studies. Moreover, the ability of HMBA to induce differentiation is advantageous for its therapeutic use when compared to cytotoxic agents. However, HMBA induced HEXIM1 expression required at mM concentrations and induced dose limiting toxicity, thrombocytopenia. Thus we structurally optimized HMBA and identified a more potent inducer of HEXIM1 expression, 4a1. The studies reported herein tested the ability of 4a1 to induce HEXIM1 activities using a combination of biochemical, cell phenotypic, and in vivo assays. 4a1 induced breast cell differentiation, including the stem cell fraction in triple negative breast cancer cells. Clinically relevant HEXIM1 activities that are also induced by 4a1 include enhancement of the inhibitory effects of tamoxifen and inhibition of breast tumor metastasis. We also provide mechanistic basis for the phenotypic effects of 4a1. Our results support the potential of an unsymmetrical HMBA derivative, such as 4a1, as lead compound for further drug development.", "correspondence": {"affiliation": {"country": "United States", "address-part": "10900 Euclid Avenue", "postal-code": "44106", "@country": "usa", "city": "Cleveland", "organization": [{"$": "Department of Pharmacology"}, {"$": "Case Western Reserve University School of Medicine"}], "state": "OH"}, "person": {"ce:given-name": "Monica M.", "ce:initials": "M.M.", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Antiestrogens", "@xml:lang": "eng"}, {"$": "Breast cells", "@xml:lang": "eng"}, {"$": "Differentiation", "@xml:lang": "eng"}, {"$": "HEXIM1", "@xml:lang": "eng"}, {"$": "HMBA", "@xml:lang": "eng"}, {"$": "Metastasis", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"website": {"ce:e-address": {"$": "www.elsevier.com/locate/canlet", "@type": "email"}}, "translated-sourcetitle": {"$": "Cancer Letters", "@xml:lang": "eng"}, "volisspag": {"voliss": {"@volume": "379", "@issue": "1"}, "pagerange": {"@first": "60", "@last": "69"}}, "@type": "j", "sourcetitle": "Cancer Letters", "publicationdate": {"month": "08", "year": "2016", "date-text": {"@xfab-added": "true", "$": "28 August 2016"}, "day": "28"}, "codencode": "CALED", "sourcetitle-abbrev": "Cancer Lett.", "@country": "irl", "issn": [{"$": "18727980", "@type": "electronic"}, {"$": "03043835", "@type": "print"}], "publicationyear": {"@first": "2016"}, "publisher": {"publishername": "Elsevier Ireland Ltd"}, "@srcid": "29160"}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "CABSCLASS", "classification": [{"classification-code": "84.5.13.3", "classification-description": "GENETICS AND MOLECULAR BIOLOGY; EUKARYOTIC GENETICS; Genetics and Cancer; Oncogenes and tumour suppressor genes"}, {"classification-code": "87.2.9.3", "classification-description": "CANCER RESEARCH; TUMOUR BIOLOGY; Genetics; Oncogenes and tumour suppressor genes"}, {"classification-code": "87.5.11", "classification-description": "CANCER RESEARCH; CLINICAL INVESTIGATIONS BY ORGAN SITE; Breast"}]}, {"@type": "EMCLASS", "classification": [{"classification-code": "16", "classification-description": "Cancer"}, {"classification-code": "29", "classification-description": "Clinical and Experimental Biochemistry"}, {"classification-code": "30", "classification-description": "Clinical and Experimental Pharmacology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}]}, {"@type": "ASJC", "classification": [{"$": "2730"}, {"$": "1306"}]}, {"@type": "SUBJABBR", "classification": [{"$": "MEDI"}, {"$": "BIOC"}]}]}, "tradenamegroup": {"tradenames": {"trademanuitem": {"tradename": "4a 1"}, "@type": "TNM"}}, "chemicalgroup": {"chemicals": [{"@source": "esbd", "chemical": [{"cas-registry-number": "17655-31-1", "chemical-name": "amide"}, {"cas-registry-number": "3073-59-4", "chemical-name": "hexamethylenebisacetamide"}, {"cas-registry-number": "10540-29-1", "chemical-name": "tamoxifen"}]}, {"@source": "nlm", "chemical": [{"chemical-name": "Acetamides"}, {"chemical-name": "Antigens, Polyomavirus Transforming"}, {"chemical-name": "Antineoplastic Agents"}, {"chemical-name": "Benzeneacetamides"}, {"chemical-name": "CDK9 protein, human"}, {"chemical-name": "Cyclin-Dependent Kinase 9"}, {"chemical-name": "hexamethylene bisacetamide"}, {"chemical-name": "HEXIM1 protein, human"}, {"chemical-name": "RNA-Binding Proteins"}, {"chemical-name": "Tamoxifen"}]}]}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "CABS"}, {"$": "EMBASE"}, {"$": "EMBIO"}, {"$": "MEDL"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "01", "@timestamp": "BST 16:29:51", "@year": "2017", "@month": "08"}}, "itemidlist": {"itemid": [{"$": "610578179", "@idtype": "PUI"}, {"$": "2016198770", "@idtype": "CABS"}, {"$": "651035499", "@idtype": "CAR-ID"}, {"$": "20160410116", "@idtype": "EMBASE"}, {"$": "2016469371", "@idtype": "EMBIO"}, {"$": "27238569", "@idtype": "MEDL"}, {"$": "20161284304", "@idtype": "REAXYSCAR"}, {"$": "2016163089", "@idtype": "RMC"}, {"$": "84971418688", "@idtype": "SCP"}, {"$": "84971418688", "@idtype": "SGR"}, {"$": "617565313", "@idtype": "PUIsecondary"}], "ce:pii": "S0304383516303421", "ce:doi": "10.1016/j.canlet.2016.05.029"}}, "tail": {"bibliography": {"@refcount": "41", "reference": [{"ref-fulltext": "Andreeff M., Stone R., Michaeli J., Young C.W., Tong W.P., Sogoloff H., et al. Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent. Blood 1992, 80:2604-2609.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "1992"}, "ref-title": {"ref-titletext": "Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent"}, "refd-itemidlist": {"itemid": {"$": "0026446246", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "80"}, "pagerange": {"@first": "2604", "@last": "2609"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Andreeff", "ce:indexed-name": "Andreeff M."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Stone", "ce:indexed-name": "Stone R."}, {"@seq": "3", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Michaeli", "ce:indexed-name": "Michaeli J."}, {"@seq": "4", "ce:initials": "C.W.", "@_fa": "true", "ce:surname": "Young", "ce:indexed-name": "Young C.W."}, {"@seq": "5", "ce:initials": "W.P.", "@_fa": "true", "ce:surname": "Tong", "ce:indexed-name": "Tong W.P."}, {"@seq": "6", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Sogoloff", "ce:indexed-name": "Sogoloff H."}], "et-al": null}, "ref-sourcetitle": "Blood"}}, {"ref-fulltext": "Young C.W., Fanucchi M.P., Declan Walsh T., Baltzer L., Yaldaei S., Stevens Y.W., et al. Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals. Cancer Res 1988, 48:7304-7309.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "1988"}, "ref-title": {"ref-titletext": "Phase I trial and clinical pharmacological evaluation of hexamethylene bisacetamide administration by ten-day continuous intravenous infusion at twenty-eight-day intervals"}, "refd-itemidlist": {"itemid": {"$": "0024265086", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48"}, "pagerange": {"@first": "7304", "@last": "7309"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.W.", "@_fa": "true", "ce:surname": "Young", "ce:indexed-name": "Young C.W."}, {"@seq": "2", "ce:initials": "M.P.", "@_fa": "true", "ce:surname": "Fanucchi", "ce:indexed-name": "Fanucchi M.P."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Declan Walsh", "ce:indexed-name": "Declan Walsh T."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Baltzer", "ce:indexed-name": "Baltzer L."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Yaldaei", "ce:indexed-name": "Yaldaei S."}, {"@seq": "6", "ce:initials": "Y.W.", "@_fa": "true", "ce:surname": "Stevens", "ce:indexed-name": "Stevens Y.W."}], "et-al": null}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Turano M., Napolitano G., Dulac C., Majello B., Bensaude O., Lania L. Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation. J. Cell. Physiol 2006, 206:603-610.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Increased HEXIM1 expression during erythroleukemia and neuroblastoma cell differentiation"}, "refd-itemidlist": {"itemid": {"$": "31944446145", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "206"}, "pagerange": {"@first": "603", "@last": "610"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Turano", "ce:indexed-name": "Turano M."}, {"@seq": "2", "ce:initials": "G.", "@_fa": "true", "ce:surname": "Napolitano", "ce:indexed-name": "Napolitano G."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Dulac", "ce:indexed-name": "Dulac C."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Majello", "ce:indexed-name": "Majello B."}, {"@seq": "5", "ce:initials": "O.", "@_fa": "true", "ce:surname": "Bensaude", "ce:indexed-name": "Bensaude O."}, {"@seq": "6", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Lania", "ce:indexed-name": "Lania L."}]}, "ref-sourcetitle": "J. Cell. Physiol"}}, {"ref-fulltext": "Conley B.A., Forrest A., Egorin M.J., Zuhowski E.G., Sinibaldi V., Van Echo D.A. Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580). Cancer Res 1989, 49:3436-3440.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1989"}, "ref-title": {"ref-titletext": "Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)"}, "refd-itemidlist": {"itemid": {"$": "0024365297", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "49"}, "pagerange": {"@first": "3436", "@last": "3440"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.A.", "@_fa": "true", "ce:surname": "Conley", "ce:indexed-name": "Conley B.A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Forrest", "ce:indexed-name": "Forrest A."}, {"@seq": "3", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Egorin", "ce:indexed-name": "Egorin M.J."}, {"@seq": "4", "ce:initials": "E.G.", "@_fa": "true", "ce:surname": "Zuhowski", "ce:indexed-name": "Zuhowski E.G."}, {"@seq": "5", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Sinibaldi", "ce:indexed-name": "Sinibaldi V."}, {"@seq": "6", "ce:initials": "D.A.", "@_fa": "true", "ce:surname": "Van Echo", "ce:indexed-name": "Van Echo D.A."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "He N., Pezda A.C., Zhou Q. Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation. Mol. Cell. Biol 2006, 26:7068-7076.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "2006"}, "ref-title": {"ref-titletext": "Modulation of a P-TEFb functional equilibrium for the global control of cell growth and differentiation"}, "refd-itemidlist": {"itemid": {"$": "33749169192", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "26"}, "pagerange": {"@first": "7068", "@last": "7076"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "He", "ce:indexed-name": "He N."}, {"@seq": "2", "ce:initials": "A.C.", "@_fa": "true", "ce:surname": "Pezda", "ce:indexed-name": "Pezda A.C."}, {"@seq": "3", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Zhou", "ce:indexed-name": "Zhou Q."}]}, "ref-sourcetitle": "Mol. Cell. Biol"}}, {"ref-fulltext": "Michels A.A., Fraldi A., Li Q., Adamson T.E., Bonnet F., Nguyen V.T., et al. Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor. EMBO J. 2004, 23:2608-2619.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Binding of the 7SK snRNA turns the HEXIM1 protein into a P-TEFb (CDK9/cyclin T) inhibitor"}, "refd-itemidlist": {"itemid": {"$": "3342967685", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "2608", "@last": "2619"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Michels", "ce:indexed-name": "Michels A.A."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Fraldi", "ce:indexed-name": "Fraldi A."}, {"@seq": "3", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li Q."}, {"@seq": "4", "ce:initials": "T.E.", "@_fa": "true", "ce:surname": "Adamson", "ce:indexed-name": "Adamson T.E."}, {"@seq": "5", "ce:initials": "F.", "@_fa": "true", "ce:surname": "Bonnet", "ce:indexed-name": "Bonnet F."}, {"@seq": "6", "ce:initials": "V.T.", "@_fa": "true", "ce:surname": "Nguyen", "ce:indexed-name": "Nguyen V.T."}], "et-al": null}, "ref-sourcetitle": "EMBO J."}}, {"ref-fulltext": "Shimizu N., Ouchida R., Yoshikawa N., Hisada T., Watanabe H., Okamoto K., et al. HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b. Proc. Natl. Acad. Sci. U S A 2005, 102:8555-8560.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "HEXIM1 forms a transcriptionally abortive complex with glucocorticoid receptor without involving 7SK RNA and positive transcription elongation factor b"}, "refd-itemidlist": {"itemid": {"$": "20844456256", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "102"}, "pagerange": {"@first": "8555", "@last": "8560"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Shimizu", "ce:indexed-name": "Shimizu N."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Ouchida", "ce:indexed-name": "Ouchida R."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Yoshikawa", "ce:indexed-name": "Yoshikawa N."}, {"@seq": "4", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Hisada", "ce:indexed-name": "Hisada T."}, {"@seq": "5", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe H."}, {"@seq": "6", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Okamoto", "ce:indexed-name": "Okamoto K."}], "et-al": null}, "ref-sourcetitle": "Proc. Natl. Acad. Sci. U S A"}}, {"ref-fulltext": "Yik J.H., Chen R., Nishimura R., Jennings J.L., Link A.J., Zhou Q. Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA. Mol. Cell 2003, 12:971-982.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Inhibition of P-TEFb (CDK9/Cyclin T) kinase and RNA polymerase II transcription by the coordinated actions of HEXIM1 and 7SK snRNA"}, "refd-itemidlist": {"itemid": {"$": "0242361319", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "12"}, "pagerange": {"@first": "971", "@last": "982"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Yik", "ce:indexed-name": "Yik J.H."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen R."}, {"@seq": "3", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Nishimura", "ce:indexed-name": "Nishimura R."}, {"@seq": "4", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Jennings", "ce:indexed-name": "Jennings J.L."}, {"@seq": "5", "ce:initials": "A.J.", "@_fa": "true", "ce:surname": "Link", "ce:indexed-name": "Link A.J."}, {"@seq": "6", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Zhou", "ce:indexed-name": "Zhou Q."}]}, "ref-sourcetitle": "Mol. Cell"}}, {"ref-fulltext": "Ogba N., Chaplin L., Doughman Y.Q., Fujinaga K., Montano M.M. HEXIM1 regulates E2/ER\u03b1-mediated expression of Cyclin D1 in mammary cells via modulation of P-TEFb. Cancer Res 2008, 68:7015-7024.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "HEXIM1 regulates E2/ER\u03b1-mediated expression of Cyclin D1 in mammary cells via modulation of P-TEFb"}, "refd-itemidlist": {"itemid": {"$": "52049092507", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "68"}, "pagerange": {"@first": "7015", "@last": "7024"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Chaplin", "ce:indexed-name": "Chaplin L."}, {"@seq": "3", "ce:initials": "Y.Q.", "@_fa": "true", "ce:surname": "Doughman", "ce:indexed-name": "Doughman Y.Q."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Fujinaga", "ce:indexed-name": "Fujinaga K."}, {"@seq": "5", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Yeh I., Song K., Wittmann B.M., Bai X., Danielpour D., Montano M.M. HEXIM1 Plays a critical role in the Inhibition of the Androgen Receptor by Antiandrogens. Biochem. J. 2014, 462:315-327.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "HEXIM1 Plays a critical role in the Inhibition of the Androgen Receptor by Antiandrogens"}, "refd-itemidlist": {"itemid": {"$": "84905904923", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "462"}, "pagerange": {"@first": "315", "@last": "327"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Yeh", "ce:indexed-name": "Yeh I."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Song", "ce:indexed-name": "Song K."}, {"@seq": "3", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Wittmann", "ce:indexed-name": "Wittmann B.M."}, {"@seq": "4", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Bai", "ce:indexed-name": "Bai X."}, {"@seq": "5", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Danielpour", "ce:indexed-name": "Danielpour D."}, {"@seq": "6", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Biochem. J."}}, {"ref-fulltext": "Chen R., Yik J.H., Lew Q.J. Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer. Biomed Res. Int 2014, 2014:232870.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Brd4 and HEXIM1: multiple roles in P-TEFb regulation and cancer"}, "refd-itemidlist": {"itemid": {"$": "84896808244", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "2014"}, "pagerange": {"@first": "232870"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Chen", "ce:indexed-name": "Chen R."}, {"@seq": "2", "ce:initials": "J.H.", "@_fa": "true", "ce:surname": "Yik", "ce:indexed-name": "Yik J.H."}, {"@seq": "3", "ce:initials": "Q.J.", "@_fa": "true", "ce:surname": "Lew", "ce:indexed-name": "Lew Q.J."}]}, "ref-sourcetitle": "Biomed Res. Int"}}, {"ref-fulltext": "Montano M.M., Doughman Y.Q., Deng H., Chaplin L., Yang J., Wang N., et al. Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor. Circ. Res 2008, 102:415-422.", "@id": "12", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Mutation of the HEXIM1 gene results in defects during heart and vascular development partly through downregulation of vascular endothelial growth factor"}, "refd-itemidlist": {"itemid": {"$": "41949107645", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "102"}, "pagerange": {"@first": "415", "@last": "422"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, {"@seq": "2", "ce:initials": "Y.Q.", "@_fa": "true", "ce:surname": "Doughman", "ce:indexed-name": "Doughman Y.Q."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Deng", "ce:indexed-name": "Deng H."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Chaplin", "ce:indexed-name": "Chaplin L."}, {"@seq": "5", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang J."}, {"@seq": "6", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang N."}], "et-al": null}, "ref-sourcetitle": "Circ. Res"}}, {"ref-fulltext": "Ogba N., Doughman Y.Q., Chaplin L.J., Hu Y., Gargesha M., Watanabe M., et al. HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland. Oncogene 2010, 29:3639-3649.", "@id": "13", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "HEXIM1 modulates vascular endothelial growth factor expression and function in breast epithelial cells and mammary gland"}, "refd-itemidlist": {"itemid": {"$": "77954087427", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "29"}, "pagerange": {"@first": "3639", "@last": "3649"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "2", "ce:initials": "Y.Q.", "@_fa": "true", "ce:surname": "Doughman", "ce:indexed-name": "Doughman Y.Q."}, {"@seq": "3", "ce:initials": "L.J.", "@_fa": "true", "ce:surname": "Chaplin", "ce:indexed-name": "Chaplin L.J."}, {"@seq": "4", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Hu", "ce:indexed-name": "Hu Y."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gargesha", "ce:indexed-name": "Gargesha M."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Watanabe", "ce:indexed-name": "Watanabe M."}], "et-al": null}, "ref-sourcetitle": "Oncogene"}}, {"ref-fulltext": "Ketchart W., Smith K.M., Krupka T., Wittmann B.M., Hu Y., Rayman P.A., et al. Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis. Oncogene 2013, 32:3829-3839.", "@id": "14", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis"}, "refd-itemidlist": {"itemid": {"$": "84882455491", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32"}, "pagerange": {"@first": "3829", "@last": "3839"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, {"@seq": "2", "ce:initials": "K.M.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith K.M."}, {"@seq": "3", "ce:initials": "T.", "@_fa": "true", "ce:surname": "Krupka", "ce:indexed-name": "Krupka T."}, {"@seq": "4", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Wittmann", "ce:indexed-name": "Wittmann B.M."}, {"@seq": "5", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Hu", "ce:indexed-name": "Hu Y."}, {"@seq": "6", "ce:initials": "P.A.", "@_fa": "true", "ce:surname": "Rayman", "ce:indexed-name": "Rayman P.A."}], "et-al": null}, "ref-sourcetitle": "Oncogene"}}, {"ref-fulltext": "Wittmann B.M., Fujinaga K., Deng H., Ogba N., Montano M.M. The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1. Oncogene 2005, 24:5576-5588.", "@id": "15", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "The breast cell growth inhibitor, estrogen down regulated gene 1, modulates a novel functional interaction between estrogen receptor alpha and transcriptional elongation factor cyclin T1"}, "refd-itemidlist": {"itemid": {"$": "24644486087", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "5576", "@last": "5588"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Wittmann", "ce:indexed-name": "Wittmann B.M."}, {"@seq": "2", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Fujinaga", "ce:indexed-name": "Fujinaga K."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Deng", "ce:indexed-name": "Deng H."}, {"@seq": "4", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "5", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Oncogene"}}, {"ref-fulltext": "Wittmann B.M., Wang N., Montano M.M. Identification of a novel inhibitor of cell growth that is down-regulated by estrogens and decreased in breast tumors. Cancer Res 2003, 63:5151-5158.", "@id": "16", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Identification of a novel inhibitor of cell growth that is down-regulated by estrogens and decreased in breast tumors"}, "refd-itemidlist": {"itemid": {"$": "0042014234", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "63"}, "pagerange": {"@first": "5151", "@last": "5158"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.M.", "@_fa": "true", "ce:surname": "Wittmann", "ce:indexed-name": "Wittmann B.M."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang N."}, {"@seq": "3", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Cancer Res"}}, {"ref-fulltext": "Devaraj S.G., Fiskus W., Shah B., Qi J., Sun B., Iyer S.P., et al. HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist. Leukemia 2016, 30:504-508.", "@id": "17", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "HEXIM1 induction is mechanistically involved in mediating anti-AML activity of BET protein bromodomain antagonist"}, "refd-itemidlist": {"itemid": {"$": "84959332179", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "504", "@last": "508"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.G.", "@_fa": "true", "ce:surname": "Devaraj", "ce:indexed-name": "Devaraj S.G."}, {"@seq": "2", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Fiskus", "ce:indexed-name": "Fiskus W."}, {"@seq": "3", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Shah", "ce:indexed-name": "Shah B."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Qi", "ce:indexed-name": "Qi J."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Sun", "ce:indexed-name": "Sun B."}, {"@seq": "6", "ce:initials": "S.P.", "@_fa": "true", "ce:surname": "Iyer", "ce:indexed-name": "Iyer S.P."}], "et-al": null}, "ref-sourcetitle": "Leukemia"}}, {"ref-fulltext": "Tan J.L., Fogley R.D., Flynn R.A., Ablain J., Yang S., Saint-Andre V., et al. Stress from nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma. Mol. Cell 2016, 62:34-46.", "@id": "18", "ref-info": {"ref-publicationyear": {"@first": "2016"}, "ref-title": {"ref-titletext": "Stress from nucleotide depletion activates the transcriptional regulator HEXIM1 to suppress melanoma"}, "refd-itemidlist": {"itemid": {"$": "84962467364", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "62"}, "pagerange": {"@first": "34", "@last": "46"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.L.", "@_fa": "true", "ce:surname": "Tan", "ce:indexed-name": "Tan J.L."}, {"@seq": "2", "ce:initials": "R.D.", "@_fa": "true", "ce:surname": "Fogley", "ce:indexed-name": "Fogley R.D."}, {"@seq": "3", "ce:initials": "R.A.", "@_fa": "true", "ce:surname": "Flynn", "ce:indexed-name": "Flynn R.A."}, {"@seq": "4", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Ablain", "ce:indexed-name": "Ablain J."}, {"@seq": "5", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Yang", "ce:indexed-name": "Yang S."}, {"@seq": "6", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Saint-Andre", "ce:indexed-name": "Saint-Andre V."}], "et-al": null}, "ref-sourcetitle": "Mol. Cell"}}, {"ref-fulltext": "Lew Q.J., Chia Y.L., Chu K.L., Lam Y.T., Gurumurthy M., Xu S., et al. Identification of HEXIM1 as a positive regulator of p53. J. Biol. Chem 2012, 287:36443-36454.", "@id": "19", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Identification of HEXIM1 as a positive regulator of p53"}, "refd-itemidlist": {"itemid": {"$": "84867835635", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "287"}, "pagerange": {"@first": "36443", "@last": "36454"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Q.J.", "@_fa": "true", "ce:surname": "Lew", "ce:indexed-name": "Lew Q.J."}, {"@seq": "2", "ce:initials": "Y.L.", "@_fa": "true", "ce:surname": "Chia", "ce:indexed-name": "Chia Y.L."}, {"@seq": "3", "ce:initials": "K.L.", "@_fa": "true", "ce:surname": "Chu", "ce:indexed-name": "Chu K.L."}, {"@seq": "4", "ce:initials": "Y.T.", "@_fa": "true", "ce:surname": "Lam", "ce:indexed-name": "Lam Y.T."}, {"@seq": "5", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Gurumurthy", "ce:indexed-name": "Gurumurthy M."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Xu", "ce:indexed-name": "Xu S."}], "et-al": null}, "ref-sourcetitle": "J. Biol. Chem"}}, {"ref-fulltext": "Ketchart W., Ogba N., Kresak A., Albert J.M., Pink J.J., Montano M.M. HEXIM1 is a critical determinant of the response to tamoxifen. Oncogene 2011, 30:3563-3569.", "@id": "20", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "HEXIM1 is a critical determinant of the response to tamoxifen"}, "refd-itemidlist": {"itemid": {"$": "80051796258", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "30"}, "pagerange": {"@first": "3563", "@last": "3569"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "3", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Kresak", "ce:indexed-name": "Kresak A."}, {"@seq": "4", "ce:initials": "J.M.", "@_fa": "true", "ce:surname": "Albert", "ce:indexed-name": "Albert J.M."}, {"@seq": "5", "ce:initials": "J.J.", "@_fa": "true", "ce:surname": "Pink", "ce:indexed-name": "Pink J.J."}, {"@seq": "6", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Oncogene"}}, {"ref-fulltext": "Dey A., Wong E., Kua N., Teo H.L., Tergaonkar V., Lane D. Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy. Cell Cycle 2008, 7:3759-3767.", "@id": "21", "ref-info": {"ref-publicationyear": {"@first": "2008"}, "ref-title": {"ref-titletext": "Hexamethylene bisacetamide (HMBA) simultaneously targets AKT and MAPK pathway and represses NF kappaB activity: implications for cancer therapy"}, "refd-itemidlist": {"itemid": {"$": "57349169255", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "7"}, "pagerange": {"@first": "3759", "@last": "3767"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Dey", "ce:indexed-name": "Dey A."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Wong", "ce:indexed-name": "Wong E."}, {"@seq": "3", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Kua", "ce:indexed-name": "Kua N."}, {"@seq": "4", "ce:initials": "H.L.", "@_fa": "true", "ce:surname": "Teo", "ce:indexed-name": "Teo H.L."}, {"@seq": "5", "ce:initials": "V.", "@_fa": "true", "ce:surname": "Tergaonkar", "ce:indexed-name": "Tergaonkar V."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Lane", "ce:indexed-name": "Lane D."}]}, "ref-sourcetitle": "Cell Cycle"}}, {"ref-fulltext": "Montano M.M., Desjardins C.L., Doughman Y.Q., Hsieh Y.H., Hu Y., Bensinger H.M., et al. Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse. Cardiovasc. Res 2013, 99:74-82.", "@id": "22", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Inducible re-expression of HEXIM1 causes physiological cardiac hypertrophy in the adult mouse"}, "refd-itemidlist": {"itemid": {"$": "84879356036", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "99"}, "pagerange": {"@first": "74", "@last": "82"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, {"@seq": "2", "ce:initials": "C.L.", "@_fa": "true", "ce:surname": "Desjardins", "ce:indexed-name": "Desjardins C.L."}, {"@seq": "3", "ce:initials": "Y.Q.", "@_fa": "true", "ce:surname": "Doughman", "ce:indexed-name": "Doughman Y.Q."}, {"@seq": "4", "ce:initials": "Y.H.", "@_fa": "true", "ce:surname": "Hsieh", "ce:indexed-name": "Hsieh Y.H."}, {"@seq": "5", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Hu", "ce:indexed-name": "Hu Y."}, {"@seq": "6", "ce:initials": "H.M.", "@_fa": "true", "ce:surname": "Bensinger", "ce:indexed-name": "Bensinger H.M."}], "et-al": null}, "ref-sourcetitle": "Cardiovasc. Res"}}, {"ref-fulltext": "Ruefli A.A., Smyth M.J., Johnstone R.W. HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance. Blood 2000, 95:2378-2385.", "@id": "23", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "HMBA induces activation of a caspase-independent cell death pathway to overcome P-glycoprotein-mediated multidrug resistance"}, "refd-itemidlist": {"itemid": {"$": "0034176015", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "95"}, "pagerange": {"@first": "2378", "@last": "2385"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.A.", "@_fa": "true", "ce:surname": "Ruefli", "ce:indexed-name": "Ruefli A.A."}, {"@seq": "2", "ce:initials": "M.J.", "@_fa": "true", "ce:surname": "Smyth", "ce:indexed-name": "Smyth M.J."}, {"@seq": "3", "ce:initials": "R.W.", "@_fa": "true", "ce:surname": "Johnstone", "ce:indexed-name": "Johnstone R.W."}]}, "ref-sourcetitle": "Blood"}}, {"ref-fulltext": "Zhong B., Lama R., Ketchart W., Montano M.M., Su B. Lead optimization of HMBA to develop potent HEXIM1 inducers. Bioorg. Med. Chem. Lett 2014, 24:1410-1413.", "@id": "24", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Lead optimization of HMBA to develop potent HEXIM1 inducers"}, "refd-itemidlist": {"itemid": {"$": "84894541407", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "1410", "@last": "1413"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Zhong", "ce:indexed-name": "Zhong B."}, {"@seq": "2", "ce:initials": "R.", "@_fa": "true", "ce:surname": "Lama", "ce:indexed-name": "Lama R."}, {"@seq": "3", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, {"@seq": "4", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Su", "ce:indexed-name": "Su B."}]}, "ref-sourcetitle": "Bioorg. Med. Chem. Lett"}}, {"ref-fulltext": "Montano M.M., Katzenellenbogen B.S. The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens. Proc. Natl. Acad. Sci. U S A 1997, 94:2581-2586.", "@id": "25", "ref-info": {"ref-publicationyear": {"@first": "1997"}, "ref-title": {"ref-titletext": "The quinone reductase gene: a unique estrogen receptor-regulated gene that is activated by antiestrogens"}, "refd-itemidlist": {"itemid": {"$": "0030898711", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "94"}, "pagerange": {"@first": "2581", "@last": "2586"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, {"@seq": "2", "ce:initials": "B.S.", "@_fa": "true", "ce:surname": "Katzenellenbogen", "ce:indexed-name": "Katzenellenbogen B.S."}]}, "ref-sourcetitle": "Proc. Natl. Acad. Sci. U S A"}}, {"ref-fulltext": "Song K., Wang H., Krebs T.L., Wang B., Kelley T.J., Danielpour D. DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells. Mol. Endocrinol 2010, 24:2019-2029.", "@id": "26", "ref-info": {"ref-publicationyear": {"@first": "2010"}, "ref-title": {"ref-titletext": "DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells"}, "refd-itemidlist": {"itemid": {"$": "77957345152", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "24"}, "pagerange": {"@first": "2019", "@last": "2029"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Song", "ce:indexed-name": "Song K."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang H."}, {"@seq": "3", "ce:initials": "T.L.", "@_fa": "true", "ce:surname": "Krebs", "ce:indexed-name": "Krebs T.L."}, {"@seq": "4", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang B."}, {"@seq": "5", "ce:initials": "T.J.", "@_fa": "true", "ce:surname": "Kelley", "ce:indexed-name": "Kelley T.J."}, {"@seq": "6", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Danielpour", "ce:indexed-name": "Danielpour D."}]}, "ref-sourcetitle": "Mol. Endocrinol"}}, {"ref-fulltext": "Yeh I.J., Ogba N., Bensigner H., Welford S.M., Montano M.M. HEXIM1 down-regulates hypoxia-inducible factor-1alpha protein stability. Biochem. J. 2013, 456:195-204.", "@id": "27", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "HEXIM1 down-regulates hypoxia-inducible factor-1alpha protein stability"}, "refd-itemidlist": {"itemid": {"$": "84887432218", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "456"}, "pagerange": {"@first": "195", "@last": "204"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.J.", "@_fa": "true", "ce:surname": "Yeh", "ce:indexed-name": "Yeh I.J."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Bensigner", "ce:indexed-name": "Bensigner H."}, {"@seq": "4", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Welford", "ce:indexed-name": "Welford S.M."}, {"@seq": "5", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Biochem. J."}}, {"ref-fulltext": "Zheng Q., Banaszak L., Fracci S., Basali D., Dunlap S.M., Hursting S.D., et al. Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells. Endocr. Relat. Cancer 2013, 20:797-808.", "@id": "28", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "Leptin receptor maintains cancer stem-like properties in triple negative breast cancer cells"}, "refd-itemidlist": {"itemid": {"$": "84890115428", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "797", "@last": "808"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "Q.", "@_fa": "true", "ce:surname": "Zheng", "ce:indexed-name": "Zheng Q."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Banaszak", "ce:indexed-name": "Banaszak L."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Fracci", "ce:indexed-name": "Fracci S."}, {"@seq": "4", "ce:initials": "D.", "@_fa": "true", "ce:surname": "Basali", "ce:indexed-name": "Basali D."}, {"@seq": "5", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Dunlap", "ce:indexed-name": "Dunlap S.M."}, {"@seq": "6", "ce:initials": "S.D.", "@_fa": "true", "ce:surname": "Hursting", "ce:indexed-name": "Hursting S.D."}], "et-al": null}, "ref-sourcetitle": "Endocr. Relat. Cancer"}}, {"ref-fulltext": "Liu M., Casimiro M.C., Wang C., Shirley L.A., Jiao X., Katiyar S., et al. p21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:19035-19039.", "@id": "29", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "P21CIP1 attenuates Ras- and c-Myc-dependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo"}, "refd-itemidlist": {"itemid": {"$": "73149086829", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "106"}, "pagerange": {"@first": "19035", "@last": "19039"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu M."}, {"@seq": "2", "ce:initials": "M.C.", "@_fa": "true", "ce:surname": "Casimiro", "ce:indexed-name": "Casimiro M.C."}, {"@seq": "3", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang C."}, {"@seq": "4", "ce:initials": "L.A.", "@_fa": "true", "ce:surname": "Shirley", "ce:indexed-name": "Shirley L.A."}, {"@seq": "5", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Jiao", "ce:indexed-name": "Jiao X."}, {"@seq": "6", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Katiyar", "ce:indexed-name": "Katiyar S."}], "et-al": null}, "ref-sourcetitle": "Proc. Natl. Acad. Sci. U.S.A."}}, {"ref-fulltext": "Cruz F.D., Matushansky I. Solid tumor differentiation therapy - is it possible?. Oncotarget 2012, 3:559-567.", "@id": "30", "ref-info": {"ref-publicationyear": {"@first": "2012"}, "ref-title": {"ref-titletext": "Solid tumor differentiation therapy - is it possible?"}, "refd-itemidlist": {"itemid": {"$": "84867326265", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "3"}, "pagerange": {"@first": "559", "@last": "567"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "F.D.", "@_fa": "true", "ce:surname": "Cruz", "ce:indexed-name": "Cruz F.D."}, {"@seq": "2", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Matushansky", "ce:indexed-name": "Matushansky I."}]}, "ref-sourcetitle": "Oncotarget"}}, {"ref-fulltext": "Thiagarajan P.S., Hitomi M., Hale J.S., Alvarado A.G., Otvos B., Sinyuk M., et al. Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer. Stem Cells 2015, 33:2114-2125.", "@id": "31", "ref-info": {"ref-publicationyear": {"@first": "2015"}, "ref-title": {"ref-titletext": "Development of a fluorescent reporter system to delineate cancer stem cells in triple-negative breast cancer"}, "refd-itemidlist": {"itemid": {"$": "84931571412", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "33"}, "pagerange": {"@first": "2114", "@last": "2125"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.S.", "@_fa": "true", "ce:surname": "Thiagarajan", "ce:indexed-name": "Thiagarajan P.S."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Hitomi", "ce:indexed-name": "Hitomi M."}, {"@seq": "3", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Hale", "ce:indexed-name": "Hale J.S."}, {"@seq": "4", "ce:initials": "A.G.", "@_fa": "true", "ce:surname": "Alvarado", "ce:indexed-name": "Alvarado A.G."}, {"@seq": "5", "ce:initials": "B.", "@_fa": "true", "ce:surname": "Otvos", "ce:indexed-name": "Otvos B."}, {"@seq": "6", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Sinyuk", "ce:indexed-name": "Sinyuk M."}], "et-al": null}, "ref-sourcetitle": "Stem Cells"}}, {"ref-fulltext": "Yeh I.J., Ogba N., Bensigner H., Welford S.M., Montano M.M. HEXIM1 downregulates Hypoxia Inducible Factor-1 alpha protein stability. Biochem. J. 2013, 456:195-204.", "@id": "32", "ref-info": {"ref-publicationyear": {"@first": "2013"}, "ref-title": {"ref-titletext": "HEXIM1 downregulates Hypoxia Inducible Factor-1 alpha protein stability"}, "refd-itemidlist": {"itemid": {"$": "84887432218", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "456"}, "pagerange": {"@first": "195", "@last": "204"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.J.", "@_fa": "true", "ce:surname": "Yeh", "ce:indexed-name": "Yeh I.J."}, {"@seq": "2", "ce:initials": "N.", "@_fa": "true", "ce:surname": "Ogba", "ce:indexed-name": "Ogba N."}, {"@seq": "3", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Bensigner", "ce:indexed-name": "Bensigner H."}, {"@seq": "4", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Welford", "ce:indexed-name": "Welford S.M."}, {"@seq": "5", "ce:initials": "M.M.", "@_fa": "true", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}]}, "ref-sourcetitle": "Biochem. J."}}, {"ref-fulltext": "Lin E.Y., Jones J.G., Li P., Zhu L., Whitney K.D., Muller W.J., et al. Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases. Am. J. Pathol 2003, 163:2113-2126.", "@id": "33", "ref-info": {"ref-publicationyear": {"@first": "2003"}, "ref-title": {"ref-titletext": "Progression to malignancy in the polyoma middle T oncoprotein mouse breast cancer model provides a reliable model for human diseases"}, "refd-itemidlist": {"itemid": {"$": "0142244181", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "163"}, "pagerange": {"@first": "2113", "@last": "2126"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.Y.", "@_fa": "true", "ce:surname": "Lin", "ce:indexed-name": "Lin E.Y."}, {"@seq": "2", "ce:initials": "J.G.", "@_fa": "true", "ce:surname": "Jones", "ce:indexed-name": "Jones J.G."}, {"@seq": "3", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Li", "ce:indexed-name": "Li P."}, {"@seq": "4", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Zhu", "ce:indexed-name": "Zhu L."}, {"@seq": "5", "ce:initials": "K.D.", "@_fa": "true", "ce:surname": "Whitney", "ce:indexed-name": "Whitney K.D."}, {"@seq": "6", "ce:initials": "W.J.", "@_fa": "true", "ce:surname": "Muller", "ce:indexed-name": "Muller W.J."}], "et-al": null}, "ref-sourcetitle": "Am. J. Pathol"}}, {"ref-fulltext": "Liu P., Xiang Y., Fujinaga K., Bartholomeeusen K., Nilson K., Price D.H., et al. Release of P-TEFb from 7SK snRNP activates HEXIM1 transcription. J. Biol. Chem 2014, 289:9918-9925.", "@id": "34", "ref-info": {"ref-publicationyear": {"@first": "2014"}, "ref-title": {"ref-titletext": "Release of P-TEFb from 7SK snRNP activates HEXIM1 transcription"}, "refd-itemidlist": {"itemid": {"$": "84898069941", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "289"}, "pagerange": {"@first": "9918", "@last": "9925"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "P.", "@_fa": "true", "ce:surname": "Liu", "ce:indexed-name": "Liu P."}, {"@seq": "2", "ce:initials": "Y.", "@_fa": "true", "ce:surname": "Xiang", "ce:indexed-name": "Xiang Y."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Fujinaga", "ce:indexed-name": "Fujinaga K."}, {"@seq": "4", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Bartholomeeusen", "ce:indexed-name": "Bartholomeeusen K."}, {"@seq": "5", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Nilson", "ce:indexed-name": "Nilson K."}, {"@seq": "6", "ce:initials": "D.H.", "@_fa": "true", "ce:surname": "Price", "ce:indexed-name": "Price D.H."}], "et-al": null}, "ref-sourcetitle": "J. Biol. Chem"}}, {"ref-fulltext": "Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol 2000, 20:2629-2634.", "@id": "35", "ref-info": {"ref-publicationyear": {"@first": "2000"}, "ref-title": {"ref-titletext": "P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II"}, "refd-itemidlist": {"itemid": {"$": "0034111019", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "20"}, "pagerange": {"@first": "2629", "@last": "2634"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.H.", "@_fa": "true", "ce:surname": "Price", "ce:indexed-name": "Price D.H."}]}, "ref-sourcetitle": "Mol. Cell. Biol"}}, {"ref-fulltext": "Cleator S.J., Ahamed E., Coombes R.C., Palmieri C. A 2009 update on the treatment of patients with hormone receptor-positive breast cancer. Clin. Breast Cancer 2009, 9(Suppl. 1):S6-S17.", "@id": "36", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "A 2009 update on the treatment of patients with hormone receptor-positive breast cancer"}, "refd-itemidlist": {"itemid": {"$": "70249088410", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "9"}, "pagerange": {"@first": "S6", "@last": "S17"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.J.", "@_fa": "true", "ce:surname": "Cleator", "ce:indexed-name": "Cleator S.J."}, {"@seq": "2", "ce:initials": "E.", "@_fa": "true", "ce:surname": "Ahamed", "ce:indexed-name": "Ahamed E."}, {"@seq": "3", "ce:initials": "R.C.", "@_fa": "true", "ce:surname": "Coombes", "ce:indexed-name": "Coombes R.C."}, {"@seq": "4", "ce:initials": "C.", "@_fa": "true", "ce:surname": "Palmieri", "ce:indexed-name": "Palmieri C."}]}, "ref-sourcetitle": "Clin. Breast Cancer"}}, {"ref-fulltext": "Lewis J.S., Jordan V.C. Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance. Mutat. Res 2005, 591:247-263.", "@id": "37", "ref-info": {"ref-publicationyear": {"@first": "2005"}, "ref-title": {"ref-titletext": "Selective estrogen receptor modulators (SERMs): mechanisms of anticarcinogenesis and drug resistance"}, "refd-itemidlist": {"itemid": {"$": "27844511538", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "591"}, "pagerange": {"@first": "247", "@last": "263"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Lewis", "ce:indexed-name": "Lewis J.S."}, {"@seq": "2", "ce:initials": "V.C.", "@_fa": "true", "ce:surname": "Jordan", "ce:indexed-name": "Jordan V.C."}]}, "ref-sourcetitle": "Mutat. Res"}}, {"ref-fulltext": "Musgrove E.A., Sutherland R.L. Cell cycle control by steroid hormones. Semin. Cancer Biol 1994, 5:381-389.", "@id": "38", "ref-info": {"ref-publicationyear": {"@first": "1994"}, "ref-title": {"ref-titletext": "Cell cycle control by steroid hormones"}, "refd-itemidlist": {"itemid": {"$": "0028522868", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "5"}, "pagerange": {"@first": "381", "@last": "389"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "E.A.", "@_fa": "true", "ce:surname": "Musgrove", "ce:indexed-name": "Musgrove E.A."}, {"@seq": "2", "ce:initials": "R.L.", "@_fa": "true", "ce:surname": "Sutherland", "ce:indexed-name": "Sutherland R.L."}]}, "ref-sourcetitle": "Semin. Cancer Biol"}}, {"ref-fulltext": "Osborne C.K. Tamoxifen in the treatment of breast cancer. N. Engl. J. Med 1998, 339:1609-1618.", "@id": "39", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "Tamoxifen in the treatment of breast cancer"}, "refd-itemidlist": {"itemid": {"$": "0032569831", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "339"}, "pagerange": {"@first": "1609", "@last": "1618"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "C.K.", "@_fa": "true", "ce:surname": "Osborne", "ce:indexed-name": "Osborne C.K."}]}, "ref-sourcetitle": "N. Engl. J. Med"}}, {"ref-fulltext": "Anderson H., Bulan S., Smith I., Dowsett M. Predictors of response to aromatase inhibitors. J. Steroid Biochem. Mol. Biol 2007, 106:49-54.", "@id": "40", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Predictors of response to aromatase inhibitors"}, "refd-itemidlist": {"itemid": {"$": "34548400315", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "106"}, "pagerange": {"@first": "49", "@last": "54"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Anderson", "ce:indexed-name": "Anderson H."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Bulan", "ce:indexed-name": "Bulan S."}, {"@seq": "3", "ce:initials": "I.", "@_fa": "true", "ce:surname": "Smith", "ce:indexed-name": "Smith I."}, {"@seq": "4", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Dowsett", "ce:indexed-name": "Dowsett M."}]}, "ref-sourcetitle": "J. Steroid Biochem. Mol. Biol"}}, {"ref-fulltext": "Zwart W., Rondaij M., Jalink K., Sharp Z.D., Mancini M.A., Neefjes J., et al. Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1. Mol. Endocrinol 2009, 23:1335-1345.", "@id": "41", "ref-info": {"ref-publicationyear": {"@first": "2009"}, "ref-title": {"ref-titletext": "Resistance to antiestrogen arzoxifene is mediated by overexpression of cyclin D1"}, "refd-itemidlist": {"itemid": {"$": "69449095853", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "23"}, "pagerange": {"@first": "1335", "@last": "1345"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "W.", "@_fa": "true", "ce:surname": "Zwart", "ce:indexed-name": "Zwart W."}, {"@seq": "2", "ce:initials": "M.", "@_fa": "true", "ce:surname": "Rondaij", "ce:indexed-name": "Rondaij M."}, {"@seq": "3", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Jalink", "ce:indexed-name": "Jalink K."}, {"@seq": "4", "ce:initials": "Z.D.", "@_fa": "true", "ce:surname": "Sharp", "ce:indexed-name": "Sharp Z.D."}, {"@seq": "5", "ce:initials": "M.A.", "@_fa": "true", "ce:surname": "Mancini", "ce:indexed-name": "Mancini M.A."}, {"@seq": "6", "ce:initials": "J.", "@_fa": "true", "ce:surname": "Neefjes", "ce:indexed-name": "Neefjes J."}], "et-al": null}, "ref-sourcetitle": "Mol. Endocrinol"}}]}}}}, "affiliation": [{"affiliation-city": "Cleveland", "@id": "60006404", "affilname": "CASE School of Medicine", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404", "affiliation-country": "United States"}, {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, {"affiliation-city": "Cleveland", "@id": "60021160", "affilname": "Cleveland Clinic Foundation", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021160", "affiliation-country": "United States"}, {"affiliation-city": "Cleveland", "@id": "60004154", "affilname": "Cleveland State University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004154", "affiliation-country": "United States"}], "coredata": {"srctype": "j", "eid": "2-s2.0-84971418688", "dc:description": "We have been studying the role of Hexamethylene bisacetamide (HMBA) Induced Protein 1 (HEXIM1) as a tumor suppressor whose expression is decreased in tamoxifen resistant and metastatic breast cancer. HMBA was considered the most potent and specific inducer for HMBA inducible protein 1 (HEXIM1) prior to our studies. Moreover, the ability of HMBA to induce differentiation is advantageous for its therapeutic use when compared to cytotoxic agents. However, HMBA induced HEXIM1 expression required at mM concentrations and induced dose limiting toxicity, thrombocytopenia. Thus we structurally optimized HMBA and identified a more potent inducer of HEXIM1 expression, 4a1. The studies reported herein tested the ability of 4a1 to induce HEXIM1 activities using a combination of biochemical, cell phenotypic, and in vivo assays. 4a1 induced breast cell differentiation, including the stem cell fraction in triple negative breast cancer cells. Clinically relevant HEXIM1 activities that are also induced by 4a1 include enhancement of the inhibitory effects of tamoxifen and inhibition of breast tumor metastasis. We also provide mechanistic basis for the phenotypic effects of 4a1. Our results support the potential of an unsymmetrical HMBA derivative, such as 4a1, as lead compound for further drug development.", "pubmed-id": "27238569", "prism:coverDate": "2016-08-28", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84971418688", "dc:creator": {"author": [{"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": [{"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:surname": "Ketchart", "@auid": "37029887800", "author-url": "https://api.elsevier.com/content/author/author_id/37029887800", "ce:indexed-name": "Ketchart W."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84971418688"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84971418688&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84971418688&origin=inward"}], "source-id": "29160", "pii": "S0304383516303421", "citedby-count": "9", "prism:volume": "379", "subtype": "ar", "dc:title": "Induction of HEXIM1 activities by HMBA derivative 4a1: Functional consequences and mechanism", "openaccess": "2", "prism:issn": "18727980 03043835", "publishercopyright": "\u00a9 2016.", "prism:issueIdentifier": "1", "subtypeDescription": "Article", "prism:publicationName": "Cancer Letters", "prism:pageRange": "60-69", "prism:endingPage": "69", "openaccessFlag": null, "prism:doi": "10.1016/j.canlet.2016.05.029", "prism:startingPage": "60", "dc:identifier": "SCOPUS_ID:84971418688", "dc:publisher": "Elsevier Ireland Ltd"}, "idxterms": {"mainterm": [{"$": "Acetamides", "@weight": "b", "@candidate": "n"}, {"$": "Animals", "@weight": "b", "@candidate": "n"}, {"$": "Antigens, Polyomavirus Transforming", "@weight": "b", "@candidate": "n"}, {"$": "Antineoplastic Agents", "@weight": "b", "@candidate": "n"}, {"$": "Benzeneacetamides", "@weight": "b", "@candidate": "n"}, {"$": "Breast Neoplasms", "@weight": "b", "@candidate": "n"}, {"$": "Cell Differentiation", "@weight": "b", "@candidate": "n"}, {"$": "Cell Movement", "@weight": "b", "@candidate": "n"}, {"$": "Cyclin-Dependent Kinase 9", "@weight": "b", "@candidate": "n"}, {"$": "Dose-Response Relationship, Drug", "@weight": "b", "@candidate": "n"}, {"$": "Drug Resistance, Neoplasm", "@weight": "b", "@candidate": "n"}, {"$": "Female", "@weight": "b", "@candidate": "n"}, {"$": "Gene Expression Regulation, Neoplastic", "@weight": "b", "@candidate": "n"}, {"$": "Humans", "@weight": "b", "@candidate": "n"}, {"$": "Mammary Neoplasms, Experimental", "@weight": "b", "@candidate": "n"}, {"$": "MCF-7 Cells", "@weight": "b", "@candidate": "n"}, {"$": "Mice, Transgenic", "@weight": "b", "@candidate": "n"}, {"$": "Molecular Structure", "@weight": "b", "@candidate": "n"}, {"$": "Neoplasm Metastasis", "@weight": "b", "@candidate": "n"}, {"$": "Neoplastic Stem Cells", "@weight": "b", "@candidate": "n"}, {"$": "Phenotype", "@weight": "b", "@candidate": "n"}, {"$": "RNA Interference", "@weight": "b", "@candidate": "n"}, {"$": "RNA-Binding Proteins", "@weight": "b", "@candidate": "n"}, {"$": "Signal Transduction", "@weight": "b", "@candidate": "n"}, {"$": "Structure-Activity Relationship", "@weight": "b", "@candidate": "n"}, {"$": "Tamoxifen", "@weight": "b", "@candidate": "n"}, {"$": "Time Factors", "@weight": "b", "@candidate": "n"}, {"$": "Transfection", "@weight": "b", "@candidate": "n"}, {"$": "Up-Regulation", "@weight": "b", "@candidate": "n"}]}, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Antiestrogens"}, {"@_fa": "true", "$": "Breast cells"}, {"@_fa": "true", "$": "Differentiation"}, {"@_fa": "true", "$": "HEXIM1"}, {"@_fa": "true", "$": "HMBA"}, {"@_fa": "true", "$": "Metastasis"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Oncology", "@code": "2730", "@abbrev": "MEDI"}, {"@_fa": "true", "$": "Cancer Research", "@code": "1306", "@abbrev": "BIOC"}]}, "authors": {"author": [{"ce:given-name": "Wannarasmi", "preferred-name": {"ce:given-name": "Wannarasmi", "ce:initials": "W.", "ce:surname": "Ketchart", "ce:indexed-name": "Ketchart W."}, "@seq": "1", "ce:initials": "W.", "@_fa": "true", "affiliation": [{"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}], "ce:surname": "Ketchart", "@auid": "37029887800", "author-url": "https://api.elsevier.com/content/author/author_id/37029887800", "ce:indexed-name": "Ketchart W."}, {"ce:given-name": "I-Ju", "preferred-name": {"ce:given-name": "I. Ju", "ce:initials": "I.J.", "ce:surname": "Yeh", "ce:indexed-name": "Yeh I.J."}, "@seq": "2", "ce:initials": "I.-J.", "@_fa": "true", "affiliation": {"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, "ce:surname": "Yeh", "@auid": "55926317600", "author-url": "https://api.elsevier.com/content/author/author_id/55926317600", "ce:indexed-name": "Yeh I.-J."}, {"ce:given-name": "Haoyan", "preferred-name": {"ce:given-name": "Haoyan", "ce:initials": "H.", "ce:surname": "Zhou", "ce:indexed-name": "Zhou H."}, "@seq": "3", "ce:initials": "H.", "@_fa": "true", "affiliation": {"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, "ce:surname": "Zhou", "@auid": "57202096401", "author-url": "https://api.elsevier.com/content/author/author_id/57202096401", "ce:indexed-name": "Zhou H."}, {"ce:given-name": "Praveena S.", "preferred-name": {"ce:given-name": "Praveena S.", "ce:initials": "P.S.", "ce:surname": "Thiagarajan", "ce:indexed-name": "Thiagarajan P.S."}, "@seq": "4", "ce:initials": "P.S.", "@_fa": "true", "affiliation": {"@id": "60021160", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021160"}, "ce:surname": "Thiagarajan", "@auid": "54279713300", "author-url": "https://api.elsevier.com/content/author/author_id/54279713300", "ce:indexed-name": "Thiagarajan P.S."}, {"ce:given-name": "Justin", "preferred-name": {"ce:given-name": "Justin", "ce:initials": "J.", "ce:surname": "Lathia", "ce:indexed-name": "Lathia J."}, "@seq": "5", "ce:initials": "J.", "@_fa": "true", "affiliation": {"@id": "60021160", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021160"}, "ce:surname": "Lathia", "@auid": "6603658152", "author-url": "https://api.elsevier.com/content/author/author_id/6603658152", "ce:indexed-name": "Lathia J."}, {"ce:given-name": "Ofer", "preferred-name": {"ce:given-name": "Ofer", "ce:initials": "O.", "ce:surname": "Reizes", "ce:indexed-name": "Reizes O."}, "@seq": "6", "ce:initials": "O.", "@_fa": "true", "affiliation": {"@id": "60021160", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021160"}, "ce:surname": "Reizes", "@auid": "6603336462", "author-url": "https://api.elsevier.com/content/author/author_id/6603336462", "ce:indexed-name": "Reizes O."}, {"ce:given-name": "Agata", "preferred-name": {"ce:given-name": "Agata", "ce:initials": "A.", "ce:surname": "Exner", "ce:indexed-name": "Exner A."}, "@seq": "7", "ce:initials": "A.", "@_fa": "true", "affiliation": {"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, "ce:surname": "Exner", "@auid": "6602815053", "author-url": "https://api.elsevier.com/content/author/author_id/6602815053", "ce:indexed-name": "Exner A."}, {"ce:given-name": "Bin", "preferred-name": {"ce:given-name": "Bin", "ce:initials": "B.", "ce:surname": "Su", "ce:indexed-name": "Su B."}, "@seq": "8", "ce:initials": "B.", "@_fa": "true", "affiliation": {"@id": "60004154", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60004154"}, "ce:surname": "Su", "@auid": "35340102700", "author-url": "https://api.elsevier.com/content/author/author_id/35340102700", "ce:indexed-name": "Su B."}, {"ce:given-name": "Monica M.", "preferred-name": {"ce:given-name": "Monica M.", "ce:initials": "M.M.", "ce:surname": "Montano", "ce:indexed-name": "Montano M.M."}, "@seq": "9", "ce:initials": "M.M.", "@_fa": "true", "affiliation": {"@id": "60006404", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60006404"}, "ce:surname": "Montano", "@auid": "16181708800", "author-url": "https://api.elsevier.com/content/author/author_id/16181708800", "ce:indexed-name": "Montano M.M."}]}}}